Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Moderna Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues410.5274.7
            Revenue growth49.4% 
Cost of goods sold615.1441.0
Gross profit-204.6-166.3
            Gross margin-49.9%-60.5%
General and administrative64.757.5
EBIT-269.4-223.8
            EBIT margin-65.6%-81.5%
Pre-tax income-256.0-215.2
Income taxes-0.11.0
            Tax rate0.0% 
Net income-0.3-0.2
            Net margin-0.1%-0.1%
 
Diluted EPS($4.18)($3.79)
Shares outstanding (diluted)0.10.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy